First National Trust’s Pfizer PFE Stock Holding History

First National Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.41M	Sell	157,158 -5,365	-3%	-$143K	0.15%	122
2025 Q4	$4.05M	Sell	162,523 -1,393	-0.8%	-$35.1K	0.14%	133
2025 Q3	$4.18M	Sell	163,916 -1,873	-1%	-$46.2K	0.14%	129
2025 Q2	$4.02M	Buy	165,789 +703	+0.4%	+$16.4K	0.15%	128
2025 Q1	$4.18M	Sell	165,086 -12,828	-7%	-$336K	0.17%	118
2024 Q4	$4.72M	Buy	177,914 +101,858	+134%	+$2.76M	0.18%	113
2024 Q3	$2.2M	Sell	76,056 -4,545	-6%	-$133K	0.09%	162
2024 Q2	$2.26M	Sell	80,601 -6,075	-7%	-$167K	0.09%	151
2024 Q1	$2.41M	Sell	86,676 -13,320	-13%	-$370K	0.1%	150
2023 Q4	$2.88M	Sell	99,996 -4,085	-4%	-$123K	0.13%	126
2023 Q3	$3.45M	Sell	104,081 -8,998	-8%	-$318K	0.16%	110
2023 Q2	$4.15M	Sell	113,079 -5,669	-5%	-$221K	0.19%	111
2023 Q1	$4.84M	Sell	118,748 -3,725	-3%	-$161K	0.26%	99
2022 Q4	$6.28M	Sell	122,473 -170	-0.1%	-$8.15K	0.33%	84
2022 Q3	$5.37M	Sell	122,643 -388	-0.3%	-$18.9K	0.31%	88
2022 Q2	$6.45M	Sell	123,031 -1,468	-1%	-$74.8K	0.36%	79
2022 Q1	$6.45M	Sell	124,499 -2,514	-2%	-$130K	0.33%	90
2021 Q4	$7.5M	Buy	127,013 +9,160	+8%	+$454K	0.39%	83
2021 Q3	$5.07M	Sell	117,853 -4,050	-3%	-$179K	0.3%	93
2021 Q2	$4.77M	Sell	121,903 -11,179	-8%	-$435K	0.29%	97
2021 Q1	$4.82M	Sell	133,082 -33,787	-20%	-$1.2M	0.32%	89
2020 Q4	$6.14M	Sell	166,869 -23,442	-12%	-$860K	0.42%	71
2020 Q3	$6.63M	Sell	190,311 -1,455	-0.8%	-$51K	0.52%	59
2020 Q2	$5.95M	Sell	191,766 -305	-0.2%	-$10.4K	0.5%	60
2020 Q1	$5.95M	Sell	192,071 -2,080	-1%	-$70.9K	0.59%	54
2019 Q4	$7.22M	Buy	194,151 +7,053	+4%	+$251K	0.59%	53
2019 Q3	$6.38M	Buy	187,098 +3,629	+2%	+$132K	0.57%	55
2019 Q2	$7.54M	Buy	183,469 +14,993	+9%	+$595K	0.7%	42
2019 Q1	$6.79M	Buy	168,476 +8,952	+6%	+$359K	0.68%	44
2018 Q4	$6.61M	Buy	159,524 +8,370	+6%	+$347K	0.74%	45
2018 Q3	$6.32M	Buy	151,154 +14,618	+11%	+$563K	0.64%	46
2018 Q2	$4.7M	Sell	136,536 -5,400	-4%	-$185K	0.52%	58
2018 Q1	$4.78M	Sell	141,936 -40,503	-22%	-$1.39M	0.54%	53
2017 Q4	$6.27M	Buy	182,439 +10,742	+6%	+$366K	0.69%	41
2017 Q3	$5.82M	Buy	171,697 +8,921	+5%	+$287K	0.67%	38
2017 Q2	$5.19M	Buy	162,776 +10,059	+7%	+$317K	0.63%	42
2017 Q1	$4.96M	Buy	152,717 +4,305	+3%	+$136K	0.64%	43
2016 Q4	$4.57M	Sell	148,412 -4,204	-3%	-$128K	0.64%	40
2016 Q3	$4.91M	Buy	152,616 +15,309	+11%	+$512K	0.74%	36
2016 Q2	$4.59M	Buy	137,307 +5,171	+4%	+$165K	0.7%	40
2016 Q1	$3.72M	Buy	132,136 +2,154	+2%	+$61.5K	0.57%	50
2015 Q4	$3.98M	Sell	129,982 -118	-0.1%	-$3.71K	0.63%	44
2015 Q3	$3.88M	Sell	130,100 -1,134	-0.9%	-$36.4K	0.67%	41
2015 Q2	$4.17M	Sell	131,234 -15,691	-11%	-$511K	0.67%	41
2015 Q1	$4.85M	Sell	146,925 -9,014	-6%	-$287K	0.83%	36
2014 Q4	$4.61M	Sell	155,939 -21,087	-12%	-$605K	0.82%	36
2014 Q3	$4.97M	Sell	177,026 -6,283	-3%	-$176K	0.94%	29
2014 Q2	$5.16M	Buy	183,309 +33,231	+22%	+$947K	1%	28
2014 Q1	$4.57M	Buy	150,078 +13,916	+10%	+$415K	0.82%	36
2013 Q4	$3.96M	Buy	136,162 +5,691	+4%	+$166K	0.72%	43
2013 Q3	$3.56M	Buy	130,471 +22,248	+21%	+$605K	0.7%	45
2013 Q2	$2.88M	Buy	+108,223	New	+$2.99M	0.59%	49

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

First National Trust's PFE Position: Q1 2026 in Review

First National Trust reduced its Pfizer (PFE) stake by 3.3% in Q1 2026, selling an estimated $143K and leaving 157,158 shares worth $4.41M. The position accounts for 0.15% of the portfolio, ranked #122.

First National Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.54M in Q2 2019. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

First National Trust held 157,158 shares of Pfizer worth $4.41M as of Q1 2026.
First National Trust sold 5,365 Pfizer shares in Q1 2026, an estimated $143K.
Pfizer made up 0.15% of First National Trust's portfolio in Q1 2026, its #122 holding.
First National Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
First National Trust's Pfizer position peaked at $7.54M in Q2 2019.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.